SEC Company Response from CASSAVA SCIENCES INC (FLNA) (CIK 0001069530) (FLNA) — Jan 28, 2019
CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)
Date: Jan. 28, 2019 · CIK: 0001069530 · Accession: 0001069530-19-000003
AI Filing Summary & Sentiment
Reasoning
Letter
Acceleration Request 012819
Pain Therapeutics, Inc.
January 28, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention:Donald E. Field
Re:Pain Therapeutics, Inc. (the “Company”) Registration Statement on Form S-1 Originally Filed December 18, 2018
Ladies and Gentlemen:
The Company hereby requests acceleration of the effective date of its Registration Statement on Form S-1, as amended (the “Securities Act”), to 4:00pm, Eastern time, on January 30, 2019 or as soon thereafter as possible.
The Company hereby acknowledges its responsibilities under the Securities Act and the Exchange Act as they relate to the proposed public offering of the securities specified in the above-referenced Registration Statement.
Please call Michael J. O’Donnell of Morrison & Foerster LLP, special counsel to the Company, at (650) 813-5977 as soon as the Registration Statement has been declared effective.
Very truly yours,
PAIN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request 012819 Pain Therapeutics, Inc. January 28, 2019 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention:Donald E. Field Re:Pain Therapeutics, Inc. (the “Company”) Registration Statement on Form S-1 Originally Filed December 18, 2018 Ladies and Gentlemen: The Company hereby requests acceleration of the effective date of its Registration Statement on Form S-1, as amended (the “Securities Act”), to 4:00pm, Eastern time, on January 30, 2019 or as soon thereafter as possible. The Company hereby acknowledges its responsibilities under the Securities Act and the Exchange Act as they relate to the proposed public offering of the securities specified in the above-referenced Registration Statement. Please call Michael J. O’Donnell of Morrison & Foerster LLP, special counsel to the Company, at (650) 813-5977 as soon as the Registration Statement has been declared effective. Very truly yours, PAIN THERAPEUTICS, INC. By: /s/ Remi Barbier Name: Remi Barbier Its: President and Chief Executive Officer